However, calpain-2 levels were significantly downregulated by calpeptin treatment, suggesting differential roles of calpain-1 and calpain-2 in the neurodegenerative process of rotenone-induced PD in rats. The gene discussed is CAPN2; the disease is Parkinson disease.